Pretransplant minimal residual disease predicts survival in mantle cell lymphoma patients undergoing autologous stem cell transplantation in complete remission

Autologous stem cell transplantation (ASCT) is standard therapy for mantle cell lymphoma (MCL) in remission following induction chemotherapy with the best results for patients in complete remission (CR). We hypothesized that evaluation of MRD prior to ASCT could further stratify outcomes for these p...

Full description

Saved in:
Bibliographic Details
Published in:Biol Blood Marrow Transplant
Main Authors: Cowan, Andrew J., Stevenson, Philip A., Cassaday, Ryan D., Graf, Solomon A., Fromm, Jonathan R., Wu, David, Holmberg, Leona A., Till, Brian G., Chauncey, Thomas R., Smith, Stephen D., Philip, Mary, Orozco, Johnnie J., Shustov, Andrei R., Green, Damian, Libby, Edward N., Bensinger, William I., Shadman, Mazyar, Maloney, David G., Press, Oliver W., Gopal, Ajay K.
Format: Artigo
Language:Inglês
Published: 2015
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716882/
https://ncbi.nlm.nih.gov/pubmed/26348890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.08.035
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items